PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
20.86%
Revenue growth exceeding 1.5x CRON.TO's 3.70%. David Dodd would verify if faster growth reflects superior business model.
17.29%
Cost growth above 1.5x CRON.TO's 2.28%. Michael Burry would check for structural cost disadvantages.
30.04%
Gross profit growth exceeding 1.5x CRON.TO's 5.61%. David Dodd would verify competitive advantages.
7.59%
Margin expansion exceeding 1.5x CRON.TO's 1.84%. David Dodd would verify competitive advantages.
-60.00%
R&D reduction while CRON.TO shows 17.15% growth. Joel Greenblatt would examine competitive risk.
-7.96%
G&A reduction while CRON.TO shows 4.56% growth. Joel Greenblatt would examine efficiency advantage.
67.21%
Marketing expense growth above 1.5x CRON.TO's 17.13%. Michael Burry would check for spending discipline.
132.35%
Other expenses growth above 1.5x CRON.TO's 55.57%. Michael Burry would check for concerning trends.
122.90%
Operating expenses growth above 1.5x CRON.TO's 11.36%. Michael Burry would check for inefficiency.
105.50%
Total costs growth above 1.5x CRON.TO's 6.73%. Michael Burry would check for inefficiency.
83.16%
Interest expense change of 83.16% while CRON.TO maintains costs. Bruce Berkowitz would investigate control.
-80.48%
D&A reduction while CRON.TO shows 47.96% growth. Joel Greenblatt would examine efficiency.
-114.58%
EBITDA decline while CRON.TO shows 47.71% growth. Joel Greenblatt would examine position.
-77.54%
EBITDA margin decline while CRON.TO shows 49.58% growth. Joel Greenblatt would examine position.
-130.61%
Both companies show declining income. Martin Whitman would check industry conditions.
-90.81%
Both companies show margin pressure. Martin Whitman would check industry conditions.
130.66%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
-75.82%
Both companies show declining income. Martin Whitman would check industry conditions.
-45.47%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-10502.49%
Both companies reducing tax expense. Martin Whitman would check patterns.
-61.23%
Both companies show declining income. Martin Whitman would check industry conditions.
-33.40%
Both companies show margin pressure. Martin Whitman would check industry conditions.
100.00%
EPS growth while CRON.TO declines. John Neff would investigate advantages.
100.00%
Diluted EPS growth while CRON.TO declines. John Neff would investigate advantages.
-100.00%
Share count reduction while CRON.TO shows 25.88% change. Joel Greenblatt would examine strategy.
-100.00%
Diluted share reduction while CRON.TO shows 25.88% change. Joel Greenblatt would examine strategy.